FREEMAN KEVIN D
SEC CIK 1522478 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | Dir | 55.3K | $242.9K | — | 23 | 2021-09-23 | 2025-12-23 |
Most active insiders at GALT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 10X Capital Management, LLC | 10% | — | $2.23M |
| 2 | Shlevin Harold H. | Dir | — | $1.56M |
| 3 | Jamil Khurram | Chief Medical Off | — | $1.44M |
| 4 | CALLICUTT JACK W | CFO | — | $944.3K |
| 5 | LEWIS JOEL | Pres, CEO, Dir | — | $620.9K |
| 6 | CZIRR JAMES C | 10% | — | $204.3K |
| 7 | FREEMAN KEVIN D | Dir | $58.6K | — |
| 8 | ELDRED KARY | Dir | $6,032 | — |
| 9 | Uihlein Richard E | Dir, 10% | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-12-23 | 2025-12-23 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| A | 2025-12-23 | 2025-12-23 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| AT | 2025-12-23 | 2025-12-23 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| 2025-07-18 | 2025-07-17 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.90 | +5,000 | 49.8K | +11% | +$14.5K | |
| 2024-12-26 | 2024-12-24 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $0.81 | +10.0K | 44.8K | +29% | +$8,100 | |
| 2024-10-17 | 2024-10-17 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.64 | +1,300 | 34.8K | +4% | +$3,432 | |
| 2024-10-16 | 2024-10-16 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.70 | +5,000 | 33.5K | +18% | +$13.5K | |
| I | 2024-10-16 | 2024-10-16 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.70 | +5,000 | 80.0K | +7% | +$13.5K |
| 2024-06-20 | 2024-06-20 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.38 | +2,500 | 28.5K | +10% | +$5,950 | |
| 2024-04-22 | 2024-04-22 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.98 | +2,500 | 26.0K | +11% | +$7,450 | |
| I | 2024-04-09 | 2024-04-09 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | W - Inherited | $0.00 | +2,063 | 18.1K | +13% | $0 |
| I | 2022-10-31 | 2022-10-28 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $1.41 | +10.0K | 75.0K | +15% | +$14.1K |
| I | 2022-05-20 | 2022-05-19 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $1.33 | +5,000 | 65.0K | +8% | +$6,650 |
| I | 2022-04-18 | 2022-04-18 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $1.71 | +5,000 | 60.0K | +9% | +$8,550 |
| AI | 2022-01-19 | 2022-01-19 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $1.96 | +5,000 | 55.0K | +10% | +$9,800 |
| I | 2022-01-19 | 2022-01-19 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $1.96 | +5,000 | 50.0K | +11% | +$9,800 |
| AI | 2021-12-15 | 2021-12-15 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.28 | +5,000 | 50.0K | +11% | +$11.4K |
| I | 2021-12-15 | 2021-12-06 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.28 | +5,000 | 50.0K | +11% | +$11.4K |
| I | 2021-12-06 | 2021-12-06 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $2.34 | +5,000 | 45.0K | +12% | +$11.7K |
| I | 2021-11-01 | 2021-10-29 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.17 | +2,000 | 40.0K | +5% | +$6,340 |
| I | 2021-10-21 | 2021-10-21 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.19 | +2,000 | 38.0K | +6% | +$6,380 |
| I | 2021-10-19 | 2021-10-19 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.37 | +3,000 | 36.0K | +9% | +$10.1K |
| I | 2021-09-23 | 2021-09-23 | GALT | GALECTIN THERAPEUTICS INC | FREEMAN KEVIN D | Dir | P - Purchase | $3.88 | +3,000 | 33.0K | +10% | +$11.6K |
Purchase Sale Sale after option exercise All abbreviations